ethylenediamine has been researched along with adamantane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gossens, C; Rothlisberger, U; Tavernelli, I | 1 |
| Chaturvedi, S; Das, G; Dwivedi, VP; Jain, P; Kumar, S; Kumari, A; Pahuja, I; Prasad, DVR; Singh, B; Singh, M | 1 |
2 other study(ies) available for ethylenediamine and adamantane
| Article | Year |
|---|---|
DNA structural distortions induced by ruthenium-arene anticancer compounds.
Topics: Adamantane; Antineoplastic Agents; Binding Sites; Calixarenes; Computer Simulation; DNA; Ethylenediamines; Guanine; Models, Chemical; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Stereoisomerism; Water | 2008 |
The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway.
Topics: Adamantane; Animals; Antitubercular Agents; Ethylenediamines; Macrophages; Mice; Mycobacterium tuberculosis; p38 Mitogen-Activated Protein Kinases; Tuberculosis | 2022 |